Literature DB >> 26417115

Robust Optimization of Biological Protocols.

Patrick Flaherty1, Ronald W Davis2.   

Abstract

When conducting high-throughput biological experiments, it is often necessary to develop a protocol that is both inexpensive and robust. Standard approaches are either not cost-effective or arrive at an optimized protocol that is sensitive to experimental variations. We show here a novel approach that directly minimizes the cost of the protocol while ensuring the protocol is robust to experimental variation. Our approach uses a risk-averse conditional value-at-risk criterion in a robust parameter design framework. We demonstrate this approach on a polymerase chain reaction protocol and show that our improved protocol is less expensive than the standard protocol and more robust than a protocol optimized without consideration of experimental variation.

Entities:  

Keywords:  Analysis of Designed Experiments; Experimental Design; Quality Control / Process Improvement; Response Surface Methods; Robust Parameter Design

Year:  2015        PMID: 26417115      PMCID: PMC4582800          DOI: 10.1080/00401706.2014.915890

Source DB:  PubMed          Journal:  Technometrics        ISSN: 0040-1706


  6 in total

1.  Optimization and troubleshooting in PCR.

Authors:  Kenneth H Roux
Journal:  Cold Spring Harb Protoc       Date:  2009-04

2.  Multiplex PCR: critical parameters and step-by-step protocol.

Authors:  O Henegariu; N A Heerema; S R Dlouhy; G H Vance; P H Vogt
Journal:  Biotechniques       Date:  1997-09       Impact factor: 1.993

Review 3.  Polymerase chain reaction.

Authors:  G Schochetman; C Y Ou; W K Jones
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

4.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  A map of human genome variation from population-scale sequencing.

Authors:  Gonçalo R Abecasis; David Altshuler; Adam Auton; Lisa D Brooks; Richard M Durbin; Richard A Gibbs; Matt E Hurles; Gil A McVean
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

6.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

  6 in total
  1 in total

1.  Optimization of tenocyte lineage-related factors from tonsil-derived mesenchymal stem cells using response surface methodology.

Authors:  Soon-Sun Kwon; Hyang Kim; Sang-Jin Shin; Seung Yeol Lee
Journal:  J Orthop Surg Res       Date:  2020-03-17       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.